Daily Stock List
Integral Technologies, Inc. (ITKG)
SmallCapVoice reported recently on Integral Technologies, Inc. (ITKG), M2 Communications, FeedBlitz, Bull in Advantage, OTC Picks reported previously, and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, Integral Technologies, Inc. engages in the discovery, development, and commercialization of electrically conductive hybrid plastics used primarily as raw materials in the production of industrial, commercial and consumer products and services around the world. They focus the majority of their resources on researching, developing and commercializing their ElectriPlast™ technologies.
ElectriPlast™ is an innovative, electrically-conductive resin-based material. Integral is the original researcher, developer and 100 percent owner of all intellectual property surrounding the ElectriPlast™ technology, and markets the ElectriPlast™ product through their wholly owned subsidiary, ElectriPlast™ Corp.
The Company's business strategy focuses on leveraging their intellectual property rights and their strengths in product design and material innovation. They are focusing their marketing efforts on securing licensing agreements for applications of their ElectriPlast™ technologies with manufacturers of products that would benefit from the incorporation of any of the ElectriPlast™ applications.
Integral Technologies is a leader in conductive hybrid plastics with a broad Intellectual Property (IP) portfolio referencing their ElectriPlast™ technology. ElectriPlast™ is a non-corrosive material. The ElectriPlast™ polymer is a compounded formulation of resin-based materials, which are conductively loaded, or doped, with a proprietary-controlled, balanced concentration of micron conductive materials, then pelletized. The conductive loading or doping within this pellet undergoes homogenization using conventional molding techniques and conventional molding equipment. The result is a product that can undergo molding into any of the infinite shapes and sizes associated with plastics, rubbers and other polymers. This is while reducing component weight by 40 percent to 60 percent.
Applications for ElectriPlast™ include Shielding Wire, Power Electronics, Connectors, and Cables; Shielding, Conduction, Batteries, Semiconductors, Heated Elements, Sensors, Antennas, and Medical Devices. Applications also include Consumer Electronics and Acoustics, Fuses, Capacitors, Resistors, RFID, Busbars and Terminals.
Last month, ElectriPlast, the wholly owned subsidiary of Integral Technologies, announced the immediate availability of ElectriPlast™- PBT/NiC, a new electrically conductive, resin-based material that has undergone engineering to meet demanding electro-magnetic shielding, thermal and mechanical properties for automotive, marine, consumer electronics, telecommunication and aerospace applications. Composed of Polybutylene Terephthalate (PBT) and nickel-plated carbon fiber, EP-PBT/NiC is resistant to solvents, cuts traditional component weight in half and is able to withstand temperatures to 215°C.
Integral Technologies, Inc. (ITKG), closed on Thursday at $0.40, up 19.05%, on 47,434 volume with 8 trades. The average volume for the last 60 days is 47,264. The 52-week low/high is $0.24/$0.75.
Optex Systems Holdings, Inc. (OPXS)
OTCPicks reported recently on Optex Systems Holdings, Inc. (OPXS), Nebula Stocks, Stock traders chat, PennyOmega.com, and DrStockPick.com did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, Optex Systems Holdings, Inc. is a leading manufacturer of optical sighting systems and assemblies. These are primarily for Department of Defense applications. The Company also manufactures and delivers several periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Founded in 1987, Optex Systems Holdings is based in Richardson, Texas.
The Company delivers their products both directly to the military services and to prime contractors. Their products undergo installation on different types of U.S. military land vehicles. These include the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles. They have been selected for installation on the Stryker family of vehicles. Optex Systems serves customers in three primary categories. These are as prime contractor (TACOM, U.S. Army, Navy and Marine Corps), as subcontractor (General Dynamics, BAE, Raytheon and Northrop) and as a supplier to foreign governments (Israel, Australia and NAMSA).
The Company delivers high volume products, under multi-year contracts, to large defense contractors. They also anticipate the opportunity to integrate some of their night vision and optical sights products into retail applications. Specific product lines include electronic sighting systems, mechanical sighting systems, laser protected glass periscopes, and laser protected plastic periscopes. Product lines also include non-laser protected plastic periscopes, Howitzer sighting systems, ship binoculars, and replacement optics such as filters and mirrors.
Yesterday, Optex Systems Holdings reported operating results for the three and six months ended April 1, 2012. Revenues for the three months ended April 1, 2012 were $3.9 million, compared to revenues during the same period one year ago of $3.8 million, representing an increase of $0.1 million or 2.6 percent. Gross margin during the three months ended April 1, 2012 was $0.64 million or 16.4 percent of revenues, compared to a gross margin of $0.59 million or 15.5 percent for the three months ended April 3, 2011. During the three months ended April 1, 2012, the Company recorded a net income applicable to common shareholders of $0.11 million, compared to a loss of ($0.12) million for the three months ended April 3, 2011, representing a decreased loss of $0.23 million.
Revenues for the six months ended April 1, 2012 were $8.1 million, compared to revenues during the same period one year ago of $8.7 million, representing a decrease of ($0.6) million or (6.9 percent). Gross margin during the six months ended April 1, 2012 was $1.3 million or 16.1 percent of revenues, compared to a gross margin of $1.3 million or 14.9 percent for the six months ended April 3, 2011. During the six months ended April 1, 2012, the Company recorded a net loss applicable to common shareholders of ($0.04) million, compared to ($0.17) million for the six months ended April 3, 2011, representing a decreased loss of $0.13 million.
Optex Systems Holdings, Inc. (OPXS), closed on Thursday at $0.02, even with yesterday’s close, on 38,000 volume with 2 trades. The average volume for the last 60 days is 35,227. The 52-week low/high is $0.001/$0.03.
Payment Data Systems, Inc. (PYDS)
StockGuru reported earlier on Payment Data Systems, Inc. (PYDS), Nebula Stocks did previously, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Payment Data Systems, Inc. is an integrated payment solutions provider to merchants and billers. The Company provides an extensive set of products to deliver premier payment acceptance. Payment Data Systems has solutions for merchants, billers, banks, service bureaus, as well as card issuers. Founded in 1998, the Company has their headquarters in San Antonio, Texas. Payment Data Systems lists on the OTC Bulletin Board.
The Company's strength is their ability to offer specifically tailored solutions for card issuance, payment acceptance, as well as bill payments. Payment Data Systems is gaining recognition in the industry and among customers as a top solutions provider for all forms of payment processing. Examples of these payment forms include all forms of Automated Clearing House (ACH) processing from Accounts Receivable Conversion (ARC) to Returned Check Collection (RCK).
They also include Credit Card Acceptance or Merchant Services, with connections to all processors, whether taken over the web or at a counter point of sale. Furthermore, payment forms include full solutions for web payments ranging from the ability to interface with more than 100 shopping carts; acceptance of all credit/debit cards; and e-checks entered by the consumer or taken over the phone by a client's Customer Service Representative. Moreover, all these payment forms can be collected through an Interactive Voice Response (IVR) system tailored to a user's requirements.
Additionally, Payment Data Systems' products include debit cards for payroll, benefits, and several other uses and include a patent-pending bill payment capability. The Company markets and sells their products and services through direct contact by their sales personnel, as well as through non-exclusive resellers.
This week, Payment Data Systems announced financial results for the quarter ended March 31, 2012. Revenues increased 65 percent to $1,295,870 for the first quarter of 2012 up from $785,262 for the first quarter of 2011 due to higher transaction growth. The operating income for the quarter ended March 31, 2012 was $58,981 compared to an operating loss of $144,017 for the first quarter of 2011.
Net income for the quarter ended March 31, 2012 was $69,072 up from a net loss of $144,017 for the first quarter of 2011. Gross profit increased 200 percent to $523,098 from $174,301 from the first quarter of 2011.
Payment Data Systems, Inc. (PYDS), closed on Thursday at $0.09, up 5.88%, on 69,488 volume with 10 trades. The average volume for the last 60 days is 20,169. The 52-week low/high is $0.01/$0.13.
Columbia Laboratories, Inc. (CBRX)
Hit and Run Candle Sticks, Dynamic Wealth Report, CoolPennyStocks, HotOTC, StockRich, BullRally, StockEgg, MadPennyStocks, PennyStockVille, PennyInvest, and StreetInsider reported earlier on Columbia Laboratories, Inc. (CBRX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Columbia Laboratories, Inc. is a specialty pharmaceutical company with corporate headquarters in Livingston, New Jersey. The Company develops drugs that improve treatment options for women's reproductive healthcare using their novel bioadhesive delivery technologies, which optimize drug delivery in a controlled, sustained manner. Columbia Laboratories has a successful history of developing proprietary, vaginally administered products for women's health indications.
The Company receives sales and royalty revenues from CRINONE® 8% (progesterone gel), which is marketed by Watson Pharmaceuticals, Inc. in the U.S and by Merck Serono S.A. in more than 60 foreign countries. Watson is pursuing FDA approval in the U.S. of progesterone vaginal gel to reduce the risk of preterm birth in women with premature cervical shortening, and Columbia maintains their financial interest in the product.
Each of Columbia Laboratories' marketed products and product candidates utilize the Company's bioadhesive drug delivery system (BDS) technology. The key ingredient in the BDS is polycarbophil, a non-immunogenic, hypoallergenic, bioadhesive polymer. Polycarbophil bonds to the cells of the body's mucosal surfaces upon administration. In their vaginally-administered products, it bonds to the vaginal epithelial cells.
In the Company's buccal products, it adheres to the cells of the oral mucosa. Once in place, the BDS releases the active drug in a controlled and sustained manner until it discharges upon normal cell turnover. This occurs every three to five days for the vaginal epithelium and up to every 24 hours for the oral mucosa.
Earlier this month, Columbia Laboratories reported financial results for the three-month period ended March 31, 2012. Highlights of the first quarter include total net revenues of $3.8 million, compared to $12.5 million for the first quarter of 2011. The 2011 quarter included $8.4 million of the amortization of the $34 million gain on the sale of the progesterone assets in July 2010 to Watson Pharmaceuticals. Amortization concluded in the second quarter of 2011.
Net product revenues were $3.1 million in the first quarter of 2012, compared to $3.5 million in the first quarter of 2011. Net income was $5.0 million, including a $6.2 million positive non-cash adjustment, or $0.06 per basic and $(0.02) per diluted share.
Columbia Laboratories, Inc. (CBRX), closed on Thursday at $0.66, down1.03%, on 451,692 volume with 1,100 trades. The average volume for the last 60 days is 824,090. The 52-week low/high is $0.62/$3.65.
Magellan Minerals Ltd. (MNM.V)
AllPennyStocks reported previously on Magellan Minerals Ltd. (MNM.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Magellan Minerals Ltd. is an exploration and development company whose shares trade on the TSX Venture Exchange. The Company has two advanced gold properties in the Tapajos Province of northern Brazil (Cuiu Cuiu and Coringa). The Cuiu Cuiu project's heyday as an alluvial gold producer was from 1972 to 1992, when it was part of the largest gold rush in history. Concerning the Company's Coringa project, the area has been worked by local miners since the late 1970's. Magellan Minerals has their headquarters in Vancouver, British Columbia.
The Company's Cuiu Cuiu project contains 100,000oz of gold in the Indicated category (3.4Mt @ 1.0g/t gold) and 1,200,000oz of gold in the Inferred category (31Mt @ 1.2g/t gold). Their Coringa project contains Measured and Indicated resources of 561,000oz of gold (3.2Mt @ 5.5g/t gold) and Inferred resources of 534,000oz of gold (5.5Mt @ 3.0g/t gold).
In early April, Magellan Minerals reported the results of continued prospecting work aimed at targeting high-grade structures at the Company's Cuiu Cuiu project located in the state of Para in northern Brazil. Highlights include 203.5 g/t gold in a grab sample from the previously unknown Quebrabunda showing located approximately 1km north of the Moreira Gomes deposit (0.7Moz comprising 14Mt @ 1.5g/t). Highlights also include 46.4 to 128.6 g/t gold in linear 1-meter chip samples from the previously unknown 6 Irmaos zone, which is between 180 and 330m immediately south of the Moreira Gomes deposit.
In addition, highlights include 7.0 to 14.9 g/t gold in grab samples from the previously unrecognized Cuiabano zone located 500m north of Moreira Gomes and 300m NE of the Machiche showing which was previously tested with one hole (3.3m @ 7.4g/t gold). Furthermore, highlights include 10.9 g/t gold in a grab sample from the previously unknown Ivo zone located 800m north of Moreira Gomes and 900m east of the Jerimum de Baixo zone.
This week, Magellan Minerals announced the closing of the previously announced transaction with Sandstorm Gold Ltd., whereby Magellan will grant Sandstorm Gold a 2.5 percent net smelter returns royalty (NSR) on the Coringa gold project and a 1.0 percent NSR on the Cuiu Cuiu gold project, both located in Para state, Brazil. As consideration, Sandstorm paid Magellan a cash payment of US$7.5 million and subscribed for one million common shares of Magellan at a price of $0.50 per share for total proceeds of $500,000.
Magellan Minerals Ltd. (MNM.V), closed on Thursday at $0.20, even with yesterday’s close, on 336,200 volume. The 52-week low/high is $0.19/$1.29.
PolyMedix, Inc. (PYMX)
Real Pennies, SmallCapVoice, SmallCapStockPlays, and PennyTrader Publisher reported earlier on PolyMedix, Inc. (PYMX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
PolyMedix, Inc. is a clinical stage biotechnology company that lists on the OTC Bulletin Board. The Company focuses on developing treatments for patients with acute care conditions with synthetic small molecule compounds that mimic the activity of large natural protein molecules, compounds referred to as biomimetics. PolyMedix is seeking strategic alliances to develop their PolyCides®, antimicrobial additives to materials, such as cosmetics, plastics and textiles, to create self-sterilizing products and surfaces, and anticoagulant reversing agents. PolyMedix has their corporate headquarters in Radnor, Pennsylvania.
The Company's lead infectious disease drug candidate is PMX-30063. This is the first of a new class of antibiotics, the defensin-mimetics, which imitates the natural human immunity and exploits a method of bacterial cell killing which should significantly reduce the risk of bacterial resistance. PMX-30063 has completed a Phase 2 clinical trial in patients with acute bacterial skin and skin structure infections (ABSSSI) caused by Staph aureus bacteria, including methicillin-resistant Staph aureus (MRSA). In the study, all evaluated doses of PMX-30063 showed efficacy comparable to the active control and were safe and generally well tolerated.
PolyMedix' product pipeline also includes PMX-60056. This is a synthetic, small-molecule designed to restore coagulation to help manage the balance of antithrombosis/anticoagulation and reduce the incidence of bleeding in certain interventional cardiology procedures, such as Percutaneous Coronary Intervention (PCI) and Coronary Arterial Bypass Graft (CABG), as well as, treat bleeding associated with low molecular weight heparins. PMX-60056 reverses the most common anticoagulants used in the hospital setting, heparin, and its derivative, low molecular weight heparin (LMWH).
Last week, PolyMedix announced an update on the development status of their anticoagulant reversing agent, PMX-60056. The Company has stopped enrollment in two clinical trials for PMX-60056. These are a Phase 2 clinical trial for reversing the anticoagulant activity of unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention procedures, and a Phase 1B/2 clinical trial for reversing the anticoagulant activity of the low molecular weight heparin enoxaparin in healthy volunteers.
In these clinical studies, PMX-60056 showed activity in neutralizing both UFH and enoxaparin, as measured by activated clotting time (ACT) and anti-factor Xa activity, respectively. The Company decided to stop enrollment in both clinical trials due to observations of reductions in blood pressure. PolyMedix believes these side effects could be addressed with PMX-60056 undergoing delivery in a larger volume over a longer infusion time. Additionally, given PolyMedix' limited resources and current capital market conditions, they have made the strategic decision to not incur additional expenses relating to the PMX-60056 program and instead are going to focus their development efforts and resources on PMX-30063.
PolyMedix, Inc. (PYMX), closed on Thursday at $0.34, up 1.52%, on 325,085 volume with 70 trades. The average volume for the last 60 days is 550,713. The 52-week low/high is $0.25/$1.50.
Ranger Gold Corp. (RNGC)
SmallCap Network, StreetAuthority Financial, Stocktwiter, Wyatt Investment Research, and The Online Investor reported previously on Ranger Gold Corp. (RNGC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Ranger Gold Corp. engages in the acquisition and exploration of mineral properties. The Company is a resource exploration enterprise exploring for gold in proven gold regions of Nevada. The Company was formerly known as Fenario, Inc. They changed their name to Ranger Gold Corp. on January 7, 2010. Incorporate in 2007, Ranger Gold has their headquarters in Reno, Nevada.
Over the coming months, Ranger Gold's intention is to explore their properties to determine whether they contain commercially exploitable reserves of gold and silver or other metals. The Company intends to rely upon outside consultants to provide all the tools needed for the exploratory work that is taking place.
Pursuant to a Property Option Agreement, dated as of November 27, 2009, with MinQuest, Ranger Gold has the option to earn a 100 percent interest in the CX Property located in Nye County, Nevada, approximately, 80 km north of Tonopah. The CX Property currently consists of 77 unpatented mining claims. By February 25, 2020, an aggregate $480,000 in annual option payments and a minimum aggregate $2,500,000 in annual exploration expenditures are due under the agreement. In September 2011, the Company completed their planned drill program on the CX Property and they are currently evaluating the results.
On March 29, 2010, Ranger Gold executed a second property option agreement with MinQuest granting the Company the right to acquire 100 percent of the mining interests of a Nevada mineral exploration property currently controlled by MinQuest. The property known as the Truman Property is in Mineral County, Nevada and currently consists of 98 unpatented claims. By March 29, 2020, an aggregate $510,000 in annual option payments and a minimum aggregate $2,500,000 in annual exploration expenditures are due under the agreement.
The Company currently plans to complete the field portion of the drill program this spring or in the early summer of this year. The Truman Project is near the center of the Walker Lane golden corridor, an historic mineral trend that hosts such significant deposits as the Goldfield District with 5.9 million ounces of gold production and reserves, and the Comstock District with historic production of 8.4 million ounces of gold and 193.5 million ounces of silver.
Ranger Gold Corp. (RNGC), closed on Thursday at $0.05, even with yesterday’s close. The average volume for the last 60 days is 9,989. The 52-week low/high is $0.04/$1.21.
PetroHunter Energy Corp. (PHUN)
Today we are reporting on PetroHunter Energy Corp. (PHUN), here at the QualityStocks Daily Newsletter.
Incorporated in the State of Maryland, PetroHunter Energy Corp. is a global oil and gas exploration and production company that lists on the OTC Bulletin Board. The Company's commitment is to acquiring and developing primarily unconventional oil and natural gas prospects that they believe have a very high probability of economic success. PetroHunter Energy's wholly-owned subsidiaries are PetroHunter Operating Co., and Sweetpea Corporation Pty Ltd. Founded in 2005, PetroHunter Energy is based in Denver, Colorado.
The Company currently owns oil and gas leasehold interests either directly or through an equity investment in Australia (Beetaloo Basin) and in Western Colorado (Piceance Basin). PetroHunter Energy has primary assets consisting of various oil and gas leases and related interests in oil and natural gas properties, including approximately 20,000 net mineral acres in Colorado and an undivided 50 percent working interest in four exploration permits comprising approximately 7,000,000 acres in Australia. This includes one well in the Beetaloo Basin of the Northern Territory in Australia.
For the remainder of fiscal 2012, PetroHunter Energy will focus on pursuing their applications for exploration permits in Australia, as well as pursuing opportunities related to these permits in the Beetaloo Basin. The Company will continue to pursue opportunities to realize some type of return in their Buckskin Mesa wellbores.
PetroHunter Energy's business model targets high quality, predominantly low risk, niche-oriented exploitation projects, with an emphasis on unconventional oil and gas prospects, many of which have been previously explored and identified, but for economic or other reasons were abandoned or shut in. The Company looks to identify and participate in projects that are either contiguous to areas with current or prior production history, contain acreage with successful test wells, or have 2-D and/or 3-D seismic data that the Company's consultant team of petroleum geologists believes present strong evidence of significant quantities of potential resources underlying the property.
PetroHunter Energy Corp. (PHUN), closed on Thursday at $0.01, down 12.00%, on 241,111 volume with 4 trades. The average volume for the last 60 days is 54,791. The 52-week low/high is $0.003/$0.02.
SilverSun Technologies, Inc. (SSNT)
The QualityStocks Daily Newsletter would like to spotlight SilverSun Technologies, Inc. (SSNT). Today, SilverSun Technologies, Inc. closed trading at $0.19, on 22,428 volume with 16 trades. The stock’s average daily volume over the past 60 days is 25,046, and its 52-week low/high is $0.005/$0.51.
SilverSun Technologies, Inc. reported its first financial results for its first quarter (ended March 31, 2012), filing SEC Form 10-QSB, and offering some tantalizing highlights, including a 5% increase in total revenues, with net service revenues rising 35% on a strong mix of software/service offerings through principal operating subsidiary, SWK Technologies.
SilverSun Technologies, Inc. (SSNT), via wholly-owned subsidiary SWK Technologies, is a premier total solutions provider specializing in business software for manufacturers and distributors. Established in 1988, the company focuses on meeting the needs of small-sized and mid-sized businesses ("SMB" marketplace) with accounting and business management products, including SilverSun's own proprietary software. The company also offers its own cloud-based solutions and provides network services (network configuration, data backup, 24/7 remote monitoring, etc.) to its clients.
SilverSun distinguishes itself from traditional software resellers by offering a wide range of value-added services, consisting primarily of programming, training, technical support, and other consulting and professional services. The company also provides software customization, data migration, business consulting, and implementation assistance for complex design environments. Currently, the company has over 1,000 active customers.
In addition to driving organic growth, SilverSun's aggressive growth strategy includes acquiring firms in the extensive and expanding SMB marketplace to create substantial value for its shareholders, employees, and partners. SilverSun aims to leverage SWK Technologies as a platform to roll up and aggregate the best and brightest ERP resellers, as well as other software companies with proprietary products that serve the SMB marketplace. The company's most recent acquisition was in January 2012.
In 2011, SilverSun increased sales 40% over the previous year and strengthened its balance sheet through the elimination of all outstanding debt. With organic sales accelerating, significant debt reduction, and great depth of expertise and resources, SilverSun is well positioned to become a dominant player in the growing business software marketplace. Disclaimer
SilverSun Technologies, Inc. Blog
SilverSun Technologies, Inc. News:
SilverSun Technologies Reports First Quarter 2012 Results
SilverSun Technologies Introduces Proprietary Series of Cloud-Based Business Management Solutions for $8.7 Billion Beer Brewing and Distribution Industry
SilverSun Technologies Issues CEO Letter
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.70, up 9.68%, on 10,000 volume with 13 trades. The stock’s average daily volume over the past 60 days is 7,453, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Reports First Quarter 2012 Financial Results
GlobalWise Provides Shareholder Update and Reports International Expansion to Latin America
GlobalWise Announces Channel Sales Partnership With the eVero Corporation
FluoroPharma Medical, Inc. (FPMI)
The QualityStocks Daily Newsletter would like to spotlight FluoroPharma Medical, Inc. (FPMI). Today, FluoroPharma Medical, Inc. closed trading at $0.76, up 1.33%, on 73,500 volume with 7 trades. The stock’s average daily volume over the past 60 days is 26,549, and its 52-week low/high is $0.56/$2.15.
FluoroPharma Medical, Inc. (FPMI) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.
The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.
By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.
The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer
FluoroPharma Medical, Inc. Company Blog
FluoroPharma Medical, Inc. News:
FluoroPharma is Granted Patent Rights for BFPET in Australia, Expanding Global Patent Position
FluoroPharma Medical Announces Phase II Study for CardioPET
FluoroPharma to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
Beacon Enterprise Solutions Group, Inc. (BEAC)
The QualityStocks Daily Newsletter would like to spotlight Beacon Enterprise Solutions Group, Inc. (BEAC). Today, Beacon Enterprise Solutions Group, Inc. closed trading at $0.1070, off by 2.73%, on 1,800 volume with 5 trades. The stock’s average daily volume over the past 60 days is 60,566, and its 52-week low/high is $0.0831/$0.47.
Beacon Enterprise Solutions Group, Inc. (BEAC) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.
Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.
Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.
Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer
Beacon Enterprise Solutions Group, Inc. Blog
Beacon Enterprise Solutions Group, Inc. News:
Beacon Enterprise Solutions Reports Results for Fiscal Second Quarter 2012
Beacon Enterprise Solutions Senior Management to Make Individual Voluntary Open Market Stock Purchases
Beacon Enterprise Solutions to Host Conference Call May 2, at 10:00 a.m. EDT to Discuss Fiscal Second Quarter Results
SilverSun Technologies, Inc., a premier total solutions provider specializing in business management applications and professional consulting services, today announced its first financial results for the three months ended March 31, 2012.
Net service revenues increased 35% to $2,549,885 from $1,886,446, offsetting the decline in software sales due largely to the closing of several major sales being pushed to the second quarter reporting period and beyond. Total revenues climbed 5% year-over-year to $2,908,859 from $2,761,445.
Notwithstanding a one-time, non-cash charge of $719,267 booked as share-based compensation expense related to previously described restructuring, SilverSun Technologies achieved income from operations on a non-GAAP basis of approximately $33,676, which compared to income from operations of $235,000 in the same period a year prior. On a GAAP reporting basis and after factoring in the one-time, non-cash expense item, loss from operations for the first quarter of 2012 totaled $685,591.
As of March 31, 2012, the company had $99,952 in cash; $1,164,352 in accounts receivable; zero long term debt; and total stockholders’ deficit of $839,623.
“We continue to be very pleased with the positive progress SilverSun is making in diversifying and expanding our principal operating subsidiary SWK Technologies’ revenue mix with proprietary software and service-oriented offerings,” Chairman, President, and CEO Mark Meller stated. “This successful strategy has helped to offset any material impact of several large Sage software sales, originally expected to close in the first quarter, being pushed or postponed into later reporting periods.”
Meller continued, “We continue to aggressively execute on our business plan. We acquired one reseller in January, and announced the signing of a letter of intent to acquire Hightower in March. We anticipate that transaction closing imminently. The Company continues to aggressively seek out acquisitions in the Small and Medium-Sized Business software marketplace, and we hope to be in a position to announce further acquisitions in the coming weeks and months.”
FluoroPharma Medical, Massachusetts-based developer of advanced imaging pharmaceuticals for use with positron emission tomography (PET), intends to become the leader in the early detection of coronary artery and alzheimer diseases, two of the most high-profile diseases in the country. Through the use of unique FluoroPharma chemical agents, PET technology will help clinicians detect and assess subtle indications of pathology long before the appearance of traditional symptoms. Early detection has long been established as a major factor in the success of disease intervention, and is also a critical tool in associated research.
The technology behind such early detection is represented by FluoroPharma’s principal products:
• CardioPET – This imaging agent exploits the dietary needs of the heart as it relates to glucose and fatty acids. By introducing a chemical group which alters the breakdown of fatty acids (the hearts main food source), clinicians can track their distribution into the heart muscle and assess health and viability.
- Agent: Muscle State Imaging Agent
- Type: Fatty Acid (Labeled with Fluorine 18)
- Condition: Coronary Artery Disease
- Status: Phase 1 clinical trials completed
• BFPET – By recognizing the electrical charge of the myocardial cell walls, this imaging agent allows a view into the blood flow of the heart, and identifies tissue with perfusion as well as mitochondrial integrity of the cells – a strong indicator for cell viability.
- Agent: Blood Flow Imaging Agent
- Type: Positively Charged Molecule (Labeled with Fluorine 18)
- Condition: Coronary Artery Disease
- Status: Phase 1 clinical trials completed
• VasoPET – By targeting active molecule receptors associated with inflammatory conditions, this imaging agent allows visualization of areas in the blood vessels that may potentially initiate thrombosis and embolism.
- Agent: Vulnerable plaque Imaging Agent
- Type: Receptor Connecting Molecule (Labeled with Fluorine 18)
- Condition: Coronary Artery Disease
- Status: Pre-Clinical studies completed
• AZPET – This imaging agent specifically seeks out and attaches to amyloid deposits in the brain. This allows a PET scan to reveal the areas where amyloid plaque has deposited, helping in the early detection of Alzheimer’s disease.
- Agent: Amyloid Deposit Imaging Agent
- Type: Molecule that targets that bind Amyloid Protein (Labeled with Fluorine 18)
- Condition: Alzheimer’s Disease
- Status: Development Stage
For more information, see the company website at www.FluoroPharma.com
In uncertain times, when the future of the economy is less than clear, it’s not surprising that businesses turn to outsourcing to fill production gaps. Outsourcing, first and foremost, means flexibility, freedom from the economic commitments inherent in operational scale-ups. In short, it’s something of a hedge against future downturns. If business heats up, you can increase your outsourcing. If business cools down, you can cut back without painful layoffs. But flexibility is only one of the benefits of outsourcing, which is why an increasing number of companies, including large global enterprises, are turning to companies like Beacon Enterprise Solutions.
Beacon, a global IT services provider, is a great example of IT outsourcing’s other key benefit. Specifically, it places at your fingertips the most advanced technologies and the most skilled technical professionals, when your company, or one of its operations, is unable or unwilling to build its own in-house IT base. One of the most basic rules of business is to maintain a focus on your core strengths, and nothing can distract attention and drain corporate energy faster than trying to keep up with the constantly morphing world of Information Technology. By leaving the headaches of IT to the IT professionals, the full force of a company’s resources can be directed at what it does best.
This requires a form of partnership with your IT provider that is rare in the industry, but it is one of Beacon’s greatest strengths. Beacon makes a point of developing long-term relationships with its corporate clients, teaming with its customers to make the kind of IT decisions that will continue to pay off for years to come. Beacon represents not only flexibility, but a mutual commitment to the future. It’s why Beacon has been able to work with demanding corporate giants like Merck, Volvo, and UPS, and why Beacon continues to be highly successful.
For additional information, visit the company’s website at www.AskBeacon.com
Today, Heavy Earth Resources, an oil and gas E&P focused on underexplored regions, such as the hydrocarbon basins in Central/South America, reported that the company has acquired the sole, issued share of a Colombia-focused company based in Barbados, also offering an update on extant operations (includes a withdrawal/transfer agreement and seismic program).
HEVI made the acquisition via a purchase and sale agreement through Heavy Earth’s Deep Core, Inc. subsidiary, for the sole issued share of Petro Vista Energy Colombia (Barbados) Corp., whose operations include a working interest in the Lower Magdalena Valley Basin, La Maye E&P Contract.
In addition HEVI, through the company’s Colombian operating subsidiary (DCX SAS), entered withdrawal/transfer agreements (closed May 15) with SK Innovation Co. Ltd (out of Korea) and Petroamerica International Corp. (Panama) for the SSJN-5 E&P Contract. This move places HEVI in a better logistical position, where the company can exploit its lower risk exploration vectors, while opening up underexplored resource areas that have tremendous potential for future production.
CEO of HEVI, Grant Draper, pointed to both of these moves as a prime example of the company’s capacity to generate shareholder value by growing the fundamentals. Draper explained that such acquisition of “highly probable and profitable working interest assets” via its subsidiaries, in what are emerging regions with proven hydrocarbon geology, as well as production track records, places HEVI in a solid acreage position to drive both future growth of shareholder value and raw output.
They key target being looked at here is the La Maye Block (testing well Noelia-1 already sunk back in Oct of 2009 and awaits testing), a some 68.3 gross acres of choice territory with perfect geologic analogs to the proximal, producing, Cienaga de Oro (sandstone target) and Cicuco (reefal limestone in and around granite) formations. La Maye is updip from the Cicuco & Boquete Fields and is primarily characterized by highly porous sandstone and shallow water.
Additionally, the company offered information on overall operations for Colombia, including the completion of 3D seismic analysis data capture (and subsequent commencement of data processing) on the northern part of the Morichito Block (designed to extend and refine extant 2D survey data, helping to quantify the resource footprint of the two primary, high-value prospects in among the multiple potential targets).
Also covered among the operational update was a declaration of commercial viability status for the company’s Morichito-5 discovery well, as well as that start of creating the requisite logistical infrastructure required to take the Morichito-5 into production some time in Q1/Q2 2013.
Today's Top 3
The QualityStocks Public Company Sponsor News